John Baynes
Impact in
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research
- Endocrinology, Diabetes and Metabolism top 0.02%
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
Papers in
-
- Advanced Glycation End Products research 128
-
- Glycosylation and Glycoproteins Research 16
- Connexins and lens biology 12
- Co-authors
- Suzanne R. Thorpe (127 shared papers)S R Thorpe (14 shared papers)Timothy J. Lyons (30 shared papers)Mahtab U. Ahmed (6 shared papers)John A. Dunn (12 shared papers)D G Dyer (11 shared papers)Kevin J. Wells‐Knecht (10 shared papers)Thomas Metz (14 shared papers)
- Journals
- Journal of Biological Chemistry (29 papers)Diabetes (17 papers)Annals of the New York Academy of Sciences (16 papers)Archives of Biochemistry and Biophysics (15 papers)Biochemical Journal (9 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
John Baynes
222 papers receiving 29.4k citations
John Baynes's Hit Papers
Peers
Comparison fields: 5 of 164
- Clinical Biochemistry 15.3k
- Endocrinology, Diabetes and Metabolism 8.3k
- Biochemistry 2.2k
- Aging 579
- Physiology 6.4k
Countries citing papers authored by John Baynes
This map shows the geographic impact of John Baynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Baynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Baynes more than expected).
Fields of papers citing papers by John Baynes
This network shows the impact of papers produced by John Baynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Baynes. The network helps show where John Baynes may publish in the future.
Co-authors
The 25 scholars most cited alongside John Baynes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of Oxidative Stress in Development of Complications in Diabetes Hit paper breakdown → | 1991 | 3326 |
| 2 | Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Hit paper breakdown → | 1999 | 2105 |
| 3 | Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. Hit paper breakdown → | 1986 | 772 |
| 4 | Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products Hit paper breakdown → | 2000 | 756 |
| 5 | The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions Hit paper breakdown → | 1996 | 723 |
| 6 | Accumulation of Maillard reaction products in skin collagen in diabetes and aging. Hit paper breakdown → | 1993 | 675 |
| 7 | Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging Hit paper breakdown → | 2003 | 632 |
| 8 | Simple non-invasive assessment of advanced glycation endproduct accumulation Hit paper breakdown → | 2004 | 608 |
| 9 | N ε-(Carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins Hit paper breakdown → | 1997 | 544 |
| 10 | Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by Glucose Hit paper breakdown → | 1995 | 530 |
| 11 | 1991 | 490 | |
| 12 | 2003 | 486 | |
| 13 | 1995 | 465 | |
| 14 | 1999 | 460 | |
| 15 | 2000 | 452 | |
| 16 | 1994 | 415 | |
| 17 | 1993 | 390 | |
| 18 | 2002 | 386 | |
| 19 | 2008 | 357 | |
| 20 | 2002 | 340 |
About John Baynes
John Baynes is a scholar working on Clinical Biochemistry, Molecular Biology, Endocrinology, Diabetes and Metabolism, Physiology and Pathology and Forensic Medicine, having authored 224 papers that have together received 30.9k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (128 papers), Natural Antidiabetic Agents Studies (48 papers), Biochemical effects in animals (38 papers), Alcohol Consumption and Health Effects (24 papers), Glycosylation and Glycoproteins Research (16 papers), Diet, Metabolism, and Disease (12 papers), Connexins and lens biology (12 papers) and Neurological Disorders and Treatments (10 papers). The work is most often cited by research in Clinical Biochemistry (15.3k citations), Endocrinology, Diabetes and Metabolism (8.3k citations), Biochemistry (2.2k citations), Aging (579 citations) and Physiology (6.4k citations). John Baynes has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Suzanne R. Thorpe, S R Thorpe, Timothy J. Lyons, Mahtab U. Ahmed, John A. Dunn, D G Dyer, Kevin J. Wells‐Knecht, Thomas Metz, Min-Xin Fu and J.F. Day. Their work appears in journals such as Journal of Biological Chemistry, Diabetes, Annals of the New York Academy of Sciences, Archives of Biochemistry and Biophysics and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.